Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a condition associated with high morbidity, mortality and cost to the community. Patients often report symptomatic improvement with short‐acting beta‐2 agonists (SABA) and anticholinergic bronchodilator medications, and both are recommended...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cochrane Database Syst Rev
Huvudupphovsmän: Appleton, Sarah, Jones, Terry, Poole, Phillippa, Pilotto, Louis, Adams, Robert, Lasserson, Toby J, Smith, Brian J, Muhammed, Julia
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2006
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513456/
https://ncbi.nlm.nih.gov/pubmed/16625543
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001387.pub2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk